Optipharm.CO.,LTD (KOSDAQ:153710)
4,615.00
+135.00 (3.01%)
At close: Jul 31, 2026
Optipharm.CO.,LTD Market Cap
Optipharm.CO.,LTD has a market cap or net worth of 67.7 billion as of July 31, 2026. Its market cap has decreased by -7.33% in one year.
Market Cap
67.70B
Enterprise Value
69.32B
Revenue
22.79B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,615.00
ChartMarket Cap Chart
Since October 26, 2018, Optipharm.CO.,LTD's market cap has decreased from 166.34B to 67.70B, a decrease of -59.30%. That is a compound annual growth rate of -10.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 67.70B | -9.51% |
| Dec 30, 2025 | 74.82B | 9.80% |
| Dec 30, 2024 | 68.14B | -33.93% |
| Dec 28, 2023 | 103.13B | 0.29% |
| Dec 29, 2022 | 102.84B | -25.09% |
| Dec 30, 2021 | 137.29B | -37.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WITHUS PHARMACEUTICAL Co.,LTD. | 85.27B |
| Daehan Nupharm | 78.60B |
| KOREA PHARMA | 77.55B |
| Sam-A Pharm. | 74.52B |
| Hwail Pharmaceutical | 73.57B |
| Polaris AI Pharma | 68.41B |
| GL Pharm Tech | 63.12B |
| Sinsin Pharmaceutical | 62.81B |